N

Nang Kuang Pharmaceutical Co Ltd
TWSE:1752

Watchlist Manager
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
Watchlist
Price: 36.6 TWD Market Closed
Market Cap: 3.7B TWD

Wall Street
Price Targets

Price Targets Summary
Nang Kuang Pharmaceutical Co Ltd

There are no price targets for Nang Kuang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Nang Kuang Pharmaceutical Co Ltd Competitors:
Price Targets
TBPH
Theravance Biopharma Inc
32% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
19% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
9% Upside
2005
SSY Group Ltd
31% Upside
6919
Caliway Biopharmaceuticals Co Ltd
48% Upside
CLN
Celon Pharma SA
21% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
6% Downside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Nang Kuang Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 1 year is 7%.

6%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nang Kuang Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 1 year is 4%.

10%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Nang Kuang Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's net income is 4%. The projected CAGR for the next 1 year is 0%.

4%
Past Growth
0%
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nang Kuang Pharmaceutical Co Ltd's stock price target?
Not Available

Nang Kuang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Nang Kuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's revenue is 6%. The projected CAGR for the next 1 year is 7%.

What is Nang Kuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 1 year is 4%.

What is Nang Kuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
0%

For the last 7 years the compound annual growth rate for Nang Kuang Pharmaceutical Co Ltd's net income is 4%. The projected CAGR for the next 1 year is 0%.

Back to Top